Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

16.92
+0.02000.12%
Volume:307.78K
Turnover:5.23M
Market Cap:1.51B
PE:-6.74
High:17.42
Open:16.91
Low:16.78
Close:16.90
52wk High:25.59
52wk Low:12.99
Shares:89.30M
Float Shares:80.30M
Volume Ratio:0.79
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5100
EPS(LYR):-3.2949
ROE:-255.93%
ROA:-18.67%
PB:100.07
PE(LYR):-5.14

Loading ...

Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Feb 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 16, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report